Gastroprotective Agent Compliance in Patients at Risk Suffering From a Gastrointestinal(GI) Ulcer

AstraZeneca

Status: Withdrawn

Conditions: Ulcer; Gastrointestinal Hemorrhage

Study type: Observational

Funder types: Industry

Identifiers

NCT01215058

NIS-PFR-DUM-2010/2

Details and patient eligibility

About

The purpose of this study is to assess gastroprotective agent compliance in patients at risk suffering from a gastrointestinal bleeding ulcer or a symptomatic ulcer with NSAID.

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients at risk suffering from a gastrointestinal bleeding ulcer or a symptomatic ulcer confirmed by endoscopy

Trial design

0 participants in 1 patient group

1